Thrombosis |
From the Division of Molecular Medicine(S.V., C.P.M., K.A.R., N.A.F.C., S.R.H.), Yerkes Regional Primate Research Center, Departments of Medicine (S.V., M.Y.S., S.B.K., S.R.H.) and Biomedical Engineering (C.P.M., S.R.H.), Emory University School of Medicine, Atlanta, Ga; Genzyme Corporation (B.W.), Cambridge, Mass; and The Atlanta Cardiovascular Research Institute (K.A.R., N.A.F.C.), Atlanta, Ga.
Correspondence to Stephen R. Hanson, PhD, 1639 Pierce Dr, Room 1129 WMB, Emory University, Atlanta, GA 30322. E-mail shanson{at}emory.edu
AbstractBiocompatible stent coatings may alleviate problems of increased (sub)acute thrombosis after stent implantation. Hyaluronic acid (HA), a ubiquitous, nonsulfated glycosaminoglycan, inhibits platelet adhesion and aggregation and prolongs bleeding when administered systemically. However, the effects of immobilized HA for reducing stent platelet deposition in vivo are unknown. We therefore quantified the antithrombotic effects of coating stainless steel stents and tubes with HA using an established baboon thrombosis model under physiologically relevant blood flow conditions. HA-coated and uncoated (control) stents (3.5 mm in diameter, n=32) and stainless steel tubes (4.0 mm in diameter, n=18) were deployed into exteriorized arteriovenous shunts of conscious, nonanticoagulated baboons. Accumulation of 111In-radiolabeled platelets was quantified by continuous gamma-camera imaging during a 2-hour blood exposure period. HA coating resulted in a significant reduction in platelet deposition in long (4 cm) tubes (0.24±0.15x109 versus 6.12±0.49x109 platelets; P<0.03), short (2 cm) stainless steel tubes (0.18±0.06x109 versus 3.03±0.56x109 platelets; P<0.008), and stents (0.82±0.20x109 versus 1.83±0.23x109 platelets; P<0.02) compared with uncoated control devices. Thus, HA coating reduces platelet thrombus formation on stainless steel stents and tubes in primate thrombosis models. These results indicate that immobilized HA may represent an attractive strategy for improving the thromboresistance of endovascular devices.
Key Words: thrombosis stents hyaluronic acid baboon
This article has been cited by other articles:
![]() |
E. R. Tamm, R. G. Carassa, D. M. Albert, B. T. Gabelt, S. Patel, C. A. Rasmussen, and P. L. Kaufman Viscocanalostomy in Rhesus Monkeys Arch Ophthalmol, December 1, 2004; 122(12): 1826 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Kolodgie, A. P. Burke, A. Farb, D. K. Weber, R. Kutys, T. N. Wight, and R. Virmani Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions: Insights Into Plaque Erosion Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1642 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Andrew, P. Monagle, G. deVeber, and A. K.C. Chan Thromboembolic Disease and Antithrombotic Therapy in Newborns Hematology, January 1, 2001; 2001(1): 358 - 374. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |